NCT01690533
- Conditions
- Anti-Infective Agents, Bronchial Diseases, Bronchitis, +11 more
- Locations
-
- Multiple Locations, Japan
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,985 public trials
746 recruiting studies
Lung Diseases, Obstructive trial results
NCT00625989
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- McMaster University Hamilton, Ontario, Canada
NCT03074942
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- Hospital Universitari Son Espases Palma, Balearic Islands, Spain
- Hospital de Sabadell Sabadell, Barcelona, Spain
- Hospital Universitario de Cruces Barakaldo, Bizkaia, Spain
- Hospital Galdakao-Usansolo Galdakao, Vizcaya, Spain
NCT01111526
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
- Locations
-
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00762931
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
- Henry Ford Health System Detroit, Michigan, United States
- William Beaumont Hospital Royal Oak, Michigan, United States
- Hennepin County Medical Center Minneapolis, Minnesota, United States
NCT03098849
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- ARCIM Institute Filderstadt, Baden-Wurttemberg, Germany
NCT01426009
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Elevation Investigational Site Phoenix, Arizona, United States
- Elevation Investigational Site Los Angeles, California, United States
- Elevation Investigational Site DeLand, Florida, United States
- Elevation Investigational SIte Madisonville, Kentucky, United States
NCT00149500
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Washington University St Louis, Missouri, United States
Completed
Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.
NCT01425801
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- Almirall Investigational Sites#6 Berlin, Germany
- Almirall Investigational Sites#4 Berlin, Germany
- Almirall Investigational Sites#1 Berlin, Germany
- Almirall Investigational Sites#3 Frankfurt, Germany
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Teva Investigational Site 10504 Birmingham, Alabama, United States
- Teva Investigational Site 10565 Homewood, Alabama, United States
- Teva Investigational Site 11527 Goodyear, Arizona, United States
- Teva Investigational Site 10516 Tucson, Arizona, United States